NT-ProBNP in AL amyloidosis: changes after chemotherapy and association with survival

被引：0
|
作者：
Wechalekar, A. D. [1 ]
Lachmann, H. J. [1 ]
Gillmore, J. D. [1 ]
Offer, M. [1 ]
Joshi, J. J. [1 ]
Hawkins, P. N. [1 ]
机构：
[1] UCL, Natl Amyloidosis Ctr, London, England
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [21] The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis
    Palladini, Giovanni
    Barassi, Alessandra
    Klersy, Catherine
    Pacciolla, Rosana
    Milani, Paolo
    Sarais, Gabriele
    Perlini, Stefano
    Albertini, Riccardo
    Russo, Paola
    Foli, Andrea
    Bragotti, Letizia Zenone
    Obici, Laura
    Moratti, Remigio
    d'Eril, Gian Vico Melzi
    Merlini, Giampaolo
    BLOOD, 2010, 116 (18) : 3426 - 3430
  • [22] Value of troponin and NT-proBNP to screen for cardiac amyloidosis after carpal tunnel syndrome surgery
    Noory, Navid
    Westin, Oscar
    Fosbol, Emil
    Maurer, Mathew S.
    Gustafsson, Finn
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 415
  • [23] IS THERE AN ASSOCIATION BETWEEN COPEPTIN AND NT-proBNP IN HEMODIALYSIS PATIENTS?
    Kim, Jae Seok
    Yang, Jae Won
    Choi, Seung Ok
    Han, Byoung Geun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 252 - 252
  • [24] Different NT-proBNP circulating levels for different types of cardiac amyloidosis
    Perfetto, Federico
    Bergesio, Franco
    Grifoni, Elisa
    Fabbri, Alessia
    Ciuti, Gabriele
    Frusconi, Sabrina
    Angelotti, Paola
    Spini, Valentina
    Cappelli, Francesco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (11) : 810 - 817
  • [25] Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change
    Anita D’Souza
    Ruta Brazauskas
    Angela Dispenzieri
    Julie Panepinto
    Kathryn E. Flynn
    Blood Cancer Journal, 11
  • [26] Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change
    D'Souza, Anita
    Brazauskas, Ruta
    Dispenzieri, Angela
    Panepinto, Julie
    Flynn, Kathryn E.
    BLOOD CANCER JOURNAL, 2021, 11 (02)
  • [27] NT-Probnp As Personalized Medicine Tool and New Biomarker Predicting Response to Chemotherapy and Survival in AML
    Graf, Irene
    Greiner, Georg
    Marculescu, Rodrig
    Gleixner, Karoline V.
    Herndlhofer, Susanne
    Stefanzl, Gabriele
    Knoebl, Paul
    Jaeger, Ulrich
    Hauswirth, Alexander
    Schwarzinger, Ilse
    Thalhammer, Renate
    Kundi, Michael
    Hoermann, Gregor
    Mitterbauer-Hohendanner, Gerlinde
    Valent, Peter
    Sperr, Wolfgang R.
    BLOOD, 2021, 138
  • [28] Analysis of NT-proBNP baseline levels in apollo as a predictor of survival in hereditary transthyretin-mediated (hATTR) amyloidosis
    Slama, M. S.
    Solomon, S.
    Adams, D.
    Coelho, T.
    Damy, T.
    Merlini, G.
    Maurer, M.
    Partisano, A. M.
    Chen, J.
    Karsten, V.
    Vest, J.
    Suhr, O.
    Kristen, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 576 - 576
  • [29] N-terminal fragment of brain natriuretic peptide (NT-ProBNP) - a new response criterion in AL amyloidosis
    Wechalekar, A. D.
    Merlini, G.
    Gillmore, J. D.
    Russo, P.
    Lachmann, H. J.
    Perlini, S.
    Whelan, C. J.
    Hawkins, P. N.
    Palladini, G.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 84 - 85
  • [30] A Longitudinal Analysis of NT-proBNP After LVAD Implantation
    Falls, C.
    Lolay, G.
    Kido, K.
    George, B.
    Omar, H.
    Guglin, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S346 - S347
12345